The organic cation W carnitine transporter OCTN2 transports carnitine in a sodium-dependent manner, whereas it transports organic cations sodium-independently. To elucidate the functional domain in OCTN2, we constructed chimeric proteins of human OCTN2 (hOCTN2) and mouse OCTN3 (mOCTN3) and introduced mutations at several amino acids conserved among human, rat and mouse OCTN2. We found that transmembrane domains (TMD) 1-7 are responsible for organic cation transport and for sodium dependence in carnitine transport. Within TMD1-7, Q180 and Q207 of hOCTN2 are the critical amino acids for the sodium dependence, and double mutation of Q180 and Q207 resulted in minimal change in transport activity when sodium was removed from the uptake medium. We propose that sodium-dependent a‹nity for carnitine is dependent on sodium recognition by these critical amino acids in hOCTN2, whereas carnitine transport by OCTN2 requires functional linkage between TMD1-7 and TMD11.
Introduction
The organic cation W carnitine transporter OCTN family consists of three members, i.e., OCTN1 (SLC22A4), OCTN2 (SLC22A5) and OCTN3 (Slc22a9). Complementary DNAs of OCTN1 and OCTN2 have been isolated from human, rat and mouse, whereas OCTN3 was found only in mouse (1) (2) (3) (4) (5) . Even though these three transporters show high homology, each has unique transport characteristics for carnitine and organic cations. OCTN1 (human) and OCTN2 transport carnitine in a sodium-dependent manner, whereas OCTN3 is a sodium-independent carnitine transporter. 5) Further, OCTN1 and OCTN2 transport organic cations in a sodium-independent fashion, but OCTN3 barely shows organic cation transport activity. [1] [2] [3] [4] [5] OCTN2 is physiologically important to maintain plasma carnitine concentration in human and mouse, 1, 4, [6] [7] [8] [9] [10] [11] [12] but the physiological W pharmacological relevance of OCTN1 and OCTN3 remains to be clariˆed.
The OCTNs form part of an organic ion transporter superfamily consisting of OCTs (SLC22A1¿3) and OATs (SLC22A6¿8 & 11), all of which are predicted to have 12 membrane-spanning domains. 13) OCTs and OATs primarily recognize cationic and anionic moieties of various organic compounds, respectively. The physiological substrate of OCTN2, carnitine, is zwitterionic, so OCTN protein is thought to be able to recognize both cationic and anionic substrates. 10, 14) From an evolutionary point of view, OCTN2 is considered to be the ancestral transporter of OATs and OCTs. 13) Therefore, recognition mechanisms may be retained in the OAT and OCT families. 13) Since these transporters have signiˆcant roles in drug disposition, it is important to clarify the structural determinants of substrate recognition in order to understand the pharmacological and pharmacokinetic relevance of each transporter. Nevertheless, at present these mechanisms are barely understood.
Because of the physiological importance of human OCTN2 (hOCTN2), more information is available in regard to the function and region relationship than in the cases of OATs and OCTs. Seth et al. constructed chimeras of human and rat OCTN2 and concluded that the regions of amino acids 1-122 (which includes transmembrane domains (TMD) 1-2) and 240-449 (TMD 5-10) are important for tetraethylammonium (TEA) transport, and 123-239 (TMD 2-5) and 450-carboxy terminus (TMD 10-12) for carnitine transport by OCTN2. 15) Moreover, among many known genetic polymorphisms of hOCTN2, several non-synonymous mutations, S467C (serine 467 to cysteine), Y211F (artiˆcial mutant) and P478L produce marked functional changes. 8, 15) Those mutations result in loss of carnitine transport ability without aŠecting TEA transport, showing that the carnitine transport mechanism is independent of TEA transport. 8, 14, 15) Our previous study of the S467C mutant showed that TMD11 (in which the both S467 and P478 are located) is involved in the sodium-sensitive recognition of the anionic moiety of carnitine and valproic acid.
14) However, we still do not fully understand the mechanism of the sodiumdependent carnitine transport by OCTN2.
In this study, we focused on the sodium dependence of carnitine transport by human OCTN2. We created chimeric proteins of hOCTN2 and mouse OCTN3 (mOCTN3). Potentially important amino acids were identiˆed from sequences conserved among OCTN2s, and mutated to the corresponding mOCTN3 amino acids. Construction of OCTN chimeric DNA: The fulllength wild-type hOCTN2 and mOCTN3 cDNAs were subcloned into the BamHI and HindIII sites of the expression vector pBK-CMV from Stratagene (La Jolla, CA, USA), respectively. The restriction site of XmnI is present in the sequences of both hOCTN2 and mOCTN3. The 0.6-kilobase fragments obtained from the digestion of hOCTN2 W pBK-CMV and mOCTN3 W pBK-CMV by XmnI and XhoI, were swapped and ligated to the rest of the fragment. The obtained chimeras were named N23, which has the hOCTN2 N-terminus and the mOCTN3 C-terminus, and N32 (vice versa). We conˆrmed the construction of the chimeras by direct DNA sequencing.
Materials and Methods

Materials
Site-directed mutagenesis: Single amino acid change was performed using a QuikChange Site-Directed Mutagenesis Kit from Stratagene. The mutation primers were constructed according to the manufacturer's instructions and hOCTN2 W pcDNA3 was used as the template. The presence of the desired mutation and the absence of unexpected mutation were conˆrmed by fulllength DNA sequencing of the hOCTN2 insert, then the mutation-bearing hOCTN2 inserts were subcloned into the intact expression vector pcDNA3 at the BamHI site.
Uptake studies by transient expression in HEK293 cells: The expression vector pcDNA3 or pBK-CMV was used to transfect HEK293 cells by means of the calcium phosphate precipitation method as described previously.
1) The cells were cultivated in Dulbecco's modiˆed Eagle's medium containing 10z fetal calf serum (Invitrogen, San Diego, CA), penicillin and streptomycin in a humidiˆed incubator at 379 C under 5z CO 2 . After 24 hr cultivation of the cells in 15-cm dishes, the expression vector was transfected by adding 20 mg and 30 mg of pcDNA3 and pBK-CMV plasmid DNA per dish, respectively. At 48 hr post-transfection, the cells were harvested with a rubber policemen, washed twice and suspended in the transport medium containing 125 mM NaCl, 4.8 mM KCl, 5.6 mM Dglucose, 1.2 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4 and 25 mM HEPES (pH 7.4).
In uptake measurement, the cell suspension and transport medium containing a radiolabeled test compound were preincubated separately for 20 min and then mixed to initiate the uptake reaction. At appropriate times, 200-mL aliquots of the mixture were withdrawn and the cells were separated from the transport medium by centrifugation in a microtube containing a mixture of silicon oil and liquid para‹n with a density of 1.03 and 3 M KOH. The resultant cell pellets were solubilized in 3 M KOH and neutralized with HCl, and the associated radioactivity was measured in a liquid scintillation counter. In kinetic analysis, uptakes of carnitine and TEA were evaluated at the designated times in the respective experiments, based on the linearity of the initial uptake of each compound. Cellular protein content was determined according to the method of Bradford using a Bio-Rad protein assay kit and bovine serum albumin as the standard. 16 ) When sodium-free conditions were required, the obtained cells were suspended in Na ＋ -free medium, in which Na ＋ was replaced isotonically with N-methyl-D-glucamine.
Data analysis: Initial uptake rates of L-[ 3 H]carnitine and [
14 C]TEA were obtained by measuring the uptake at 1, 5 or 30 min, respectively, and the uptake values were usually expressed as the cell-to-medium concentration (C W M) ratio ( mL W mg protein W 1, 5 or 30 min) obtained by dividing the uptake amount by the concentration of test compound in the medium. To estimate kinetic parameters for saturable transport, the uptake rate wasˆtted to the following equations by means of nonlinear least-squares regression analysis using MULTI. 17) v＝Vmax×s W (Km＋s)
( 1) where v and s are the uptake rate and concentration of substrate (carnitine or TEA), and Km and Vmax are the half-saturation concentration (Michaelis constant) and the maximum transport rate, respectively. All data were expressed as mean±S.E.M. except for the results of MULTI (mean±S.D.). Statistical analysis was performed by using Student's t-test. The criterion of signiˆcance was taken to be pº0.05.
Results
The OCTN family of transporters in human, rat and mouse shows a higher degree of amino acid identity (approximately 60z) than the OCT (¿30z) and OAT (¿15z) families, even though there are distinct diŠer-ences in transport properties among the three OCTNs. Homology among all OCTN2s and mOCTN3 is 75z, implying that diŠerences in only 100 amino acids are responsible for the variations in transporter characteristics. From amino acid alignment of OCTN2s and OCTN3, the residues speciˆc to OCTN3 are located mainly in two regions, amino acids 170-210 and the cytoplasmic C-terminus (Fig. 1) . The chimeric protein constructs well divided those two regions, with a border located at amino acids 378-379.
Sodium-sensitive region located in TMD1-7: In sodium-containing buŠer, [ 3 H]carnitine uptake by hOCTN2 was highly sodium-dependent and was also signiˆcantly greater than that by mOCTN3 (Fig. 2) , in accordance with previous reports. 5, 9) Carnitine uptake activities of both chimeras were signiˆcantly lower than that of hOCTN2, but were comparative to that of mOCTN3 in sodium-containing buŠer. This result implies that the highly eŠective carnitine uptake by hOCTN2 can not be accounted for by either TMD1-7 or TMD8-12 solely, but cooperative functions between these two domains are needed although further studies are required to examine the expression level of each construct.
Sodium-independent carnitine uptake activities were 10.4z, 13.3z, 41.4z and 51.1z of those in sodiumcontaining buŠer for hOCTN2, N23, N32 and mOCTN3, respectively. Interestingly, N23 possessed almost the same sodium dependency as hOCTN2, whereas N32 exhibited a similar level to mOCTN3. In this regard, the similar sodium dependency of N23 and hOCTN2 indicated that sodium dependence of carnitine uptake may be associated with the TMD1-7 domain of hOCTN2. According to a previous report, mOCTN3 is a sodium-independent carnitine transporter with comparable levels of carnitine uptake in both sodiumcontaining and sodium-free buŠer. 5) This apparent discrepancy may be attributable to diŠerences in uptake time (5 min vs. 10 min) or cell preparation in sodiumfree medium (10 min vs. 20 min).
To examine the sodium eŠect on carnitine a‹nity to OCTN proteins, we calculated the Michaelis-Menten constant (Km) from the concentration-dependent uptake up to 100 mM carnitine. We found that hOCTN2 showed a signiˆcant decrease of carnitine a‹nity (4.46 mM to 59.1 mM) when sodium was removed from the uptake medium ( Table 1) . On the other hand, mOCTN3 barely changed its a‹nity even in the sodiumfree condition (2.92 mM vs. 3.86 mM). In the same manner, N32 did not exhibit a sodium-dependent Km change, while N23 showed a decrease in a‹nity on removal of sodium from the uptake medium. These a‹nity changes were compatible with the relative uptake by each transporter (Fig. 2B) . This implies that the TMD1-7 region has a role in promoting eŠective transport by changing its a‹nity for carnitine in the presence of an extracellular sodium-rich environment. On the other hand, Vmax values were comparable under sodium-containing and sodium-free conditions in all cases ( Table 1) .
Signiˆcant role of Q180 and Q207 in sodium activation: There are two hot regions for OCTN3-speciˆc amino acids (Fig. 1) , and the chimera studies indicated that the TMD1-7 region might be responsible for the sodium dependence of carnitine uptake by OCTN2. We selected amino acids likely to be critical for sodium activation from hOCTN2 according to the following criteria and mutated those amino acids to the corresponding OCTN3 amino acids. Firstly, we looked for Fig. 1 . Sequence alignment for OCTN2 and OCTN3 transporters. Isoforms of OCTN2 and OCTN3 are shown. The Clustal W program was used to generate the alignment. Arrowheads indicate OCTN3-speciˆc amino acids, each of which replaces by the same amino acid in all OCTN2s. All the sequences were obtained from GenBank; mOCTN2 (AB015800, 557 residues), rOCTN2 (NM019269, 557 residues), hOCTN2 (AB015050, 557 residues) and mOCTN3 (AB018436, 564 residues). TMD regions were predicted by the TopPredII program using the hOCTN2 sequence. anionic amino acid residues, Asp and Glu, which are conserved in all OCTN2s, but changed to other amino acids in mOCTN3, because sodium binding may require ionic interaction with negatively charged residues. Further, we considered OCTN3-speciˆc amino acids with cationic residues, such as His, Arg and Lys, because sodium-derived functions may be replaceable by those positively charged amino acids. Secondly, these potentially important amino acids should be located within the putative transmembrane domains or extracellular domain near TMDs of OCTN2, considering that the sodium-rich environment is located outside the plasma membrane. On this basis, we prepared the mutants Q180H, Q207H and F489R in which each amino acid in hOCTN2 was replaced by that at the corresponding position in mOCTN3. There was no anionic amino acid that satisˆed the above criteria. F489R does not belong to TMD1-7, but is located between TMD11 and TMD12.
Q207H, Q180H and F489R mutants exhibited decreased carnitine uptake compared with hOCTN2, but still exhibited much higher uptake activities than mOCTN3 in sodium-containing buŠer (Fig. 3) . The Q207H and Q180H mutants showed a considerable increase of uptake activity in sodium-free medium. The double mutant, Q180H W Q207H showed an additional increase over Q180H or Q207H in sodium-free medium, and its relative uptake increased from about 30z to 51.7z, which is close to the value of 60.6z of mOCTN3 or N32. However, F489R retained an hOCTN2-like sodium dependence of carnitine uptake. These results were consistent with the chimera studies and supported the idea of the importance of the TMD1-7 region in sodium-dependent carnitine uptake.
The eŠects of those mutations on carnitine a‹nity are summarized in Table 2 . Q180H, Q207H and Q180H W Q207H increased the carnitine a‹nity, whereas F489R showed no apparent change in sodium-containing buŠer. Moreover, only F489R and Q207H showed a sodium-dependent a‹nity change like hOCTN2, while Q180H and Q180H W Q207H exhibited no marked Km change, like mOCTN3. These results indicated that both Q180 and Q207 are key amino acids for sodium-dependent carnitine recognition by OCTN2. Further studies are required to test the hypothesis that histidine residues may be involved in the a‹nity increase of mOCTN3 via a sodium-mimetic mechanism. However, the F489R mutant showed almost the same characteristics as hOCTN2, except for decreased uptake activity. We could notˆnd any signiˆcant role for this position.
Since the Q180H and Q207H mutants mimicked mOCTN3-like carnitine uptake, these amino acids have pivotal roles to increase the a‹nity to carnitine in the sodium-dependent carnitine transport by OCTN2.
TMD1-7 region responsible for organic cation recognition and transport: TEA is a typical organic cation model compound and is widely used for transport studies. N23 and N32 showed totally diŠerent TEA uptake potency (Fig. 4) . N23 was comparable to hOCTN2, whereas N32 completely lacked TEA uptake ability. Considering that carnitine uptake was still observed by N32 (Fig. 2) , this result may suggest that the major region responsible for TEA uptake was TMD1-7 although the expression level of each construct is required to be determined. The TEA uptakes by Q180H or Q207H were comparable to that of OCTN2, and Q180H W Q207H exhibited a decreased uptake activity compared with OCTN2, but still retained some activity, in contrast to mOCTN3 (Fig. 5) . Thus, it is not likely that these two amino acids are critical in the recognition of TEA by OCTN2. In short, TMD1-7 was concluded to be the region responsible for TEA uptake, but Q180 and Q207 do not play key roles in TEA transport, even though the combination of both mutations decreased TEA transport ability.
Minor eŠect of the acyl moiety on carnitine recognition: We used carnitine analogs as carnitine uptake inhibitors to investigate further the substrate-speciˆcity of the OCTN transporter. Those analogs vary only in the acyl moiety. The inhibition proˆles were similar among all of the wild types and chimeras, implying that OCTN might not possess any particular region that discriminates the acyl moiety of carnitine derivatives, or the acyl moiety is not as important as betaine structure in substrate recognition (Fig. 6) .
Discussion
This study clearly demonstrated that TMD1-7 creates sodium-sensitive a‹nity for carnitine and is possibly involved in the transport of organic cations. Our previous study indicated the involvement of TMD11 in anionic moiety recognition.
14) The current study on chimeras has established the critical role of cooperative interaction between TMD1-7 and TMD8-12 for highlevel carnitine uptake. Overall, sodium, anion and cation recognition at diŠerent sites seems to be involved in carnitine transport.
Wang et al. proposed that E452 is involved in the sodium a‹nity of OCTN2. 18) However, E452 is located in the cytoplasma region between TMD10-11, and is conserved in both OCTN2s and OCTN3. Thus, it seems unlikely that E452 is directly involved in sodium binding. Moreover, Seth et al. suggested that nine tyrosine residues located in or near TMDs were not involved in sodium activation of carnitine transport. 15) This result is compatible with the presentˆnding that the sodium activation of carnitine uptake involves TMD1-7, which contains both Q180 and Q207. Although further studies are needed to clarify the roles of Q180 and Q207 in sodium activation, the double mutant Q180H W Q207H clearly exhibited sodium-independent carnitine recognition, like OCTN3 ( Table 2, Fig. 3) . Moreover, since sodium-independent uptake by Q180H W Q207H suggested an additive eŠect of Q180H and Q207H, the two histidine residues appear to contribute diŠerently to sodium-independent carnitine recognition. In extracting the key amino acids, we assumed that cationic residues could have a sodium-mimetic role in OCTN3, resulting in sodium-independent carnitine uptake. Accordingly, Q180H W Q207H may mimic the sodium-activated conformation of OCTN2; in other words, the physiological OCTN3 conformation may be very similar to the sodium-activated structure of OCTN2.
We previously reported that S467C mutation resulted in the remarkable decrease in carnitine (twitterionic compound) transport with minimal change in TEA (cationic compound) transport. 14) Our analysis revealed that anionic moiety recognition by OCTN2 was sodiumdependent and S467C mutation, located in TMD11, aŠects anion recognition without any in‰uence on organic cation or sodium recognition. 14) Since the present results indicate that TMD1-7 governs the sodiumdependent a‹nity change, this region may be functionally and W or spatially coupled with TMD11. As discussed above, OCTN2 may undergo a sodium-derived conformational change and consequently, this change to activate anionic moiety recognition may involve TMD11. On the other hand, anionic recognition by OCTN3 may always be activated due to the sodiummimetic function of H180 and H207. This idea is consistent with the observation that OCTN3 shows high a‹nity to carnitine both in the presence and absence of sodium ( Table 1) .
Organic cation transport by OCTN2 is sodiumindependent, 5, 9, 10, 12) implying that sodium does not share the same site in TMD1-7 with organic cations. Further, it is likely that carnitine shares the common recognition site with organic cations, because TEA uptake by OCTN2 is competitively inhibited by carnitine. 14) In this study, N32 and N3 lacked TEA uptake even though N23 retained intact uptake (Fig. 4) . Therefore, the binding site for organic cations could be mainly located in TMD1-7, and is independent of the sodium binding site although theˆnal conclusion should be obtained after the expression and localization of each chimeric protein are clariˆed. However, loss of TEA uptake activity by OCTN3 does not necessarily mean that OCTN3 does not possess the organic cation binding site, because a considerable inhibitory eŠect of organic cations on carnitine uptake by OCTN3 has been reported. 5) This implies that OCTN3 still uses betaine structure for carnitine recognition, but is not capable of translocating organic cations. The carnitine uptake by N32 was also inhibited by organic cations such as TEA (data not shown). Accordingly, TMD 1-7 of OCTN2 is not only the binding site of the cationic moiety, but also the translocating site of organic cations.
Our current results are consistent with Seth's model. 15) According to their model, both TMD1-2 and TMD5-10 are responsible for TEA uptake while both TMD2-5 and TMD10-12 are required for carnitine uptake. Ourˆndings on the roles of Q180 (TMD3), Q207 (TMD4) and TMD11 in sodium dependence and anionic recognition for carnitine transport are consistent with this. For organic cation transport, two regions, TMD1-2 and TMD5-7 are common between the current study and Seth's model. Key amino acids for organic cation recognition and transport may be located in these regions.
In summary, we demonstrated that TMD1-7 is responsible for both organic cation transport and sodium activation. Within TMD1-7, Q180 and Q207 have a pivotal role in the sodium dependence of carnitine transport by OCTN2. Therefore, OCTN2 recognizes the cationic moiety of carnitine at TMD1-7, sodium at Q180 and Q207, and the anionic moiety at TMD11. Moreover, the recognition mechanisms may be retained in the OAT and OCT families because of the considerable level of homology among the families. In this regard, clarifying the transport mechanism of carnitine by OCTNs could help to identify the structural determinants for xenobiotic transport by OATs and OCTs. Thus, theseˆndings provide basic data on the molecular mechanism of transport not only for physiological substrates, but also for xenobiotics.
